期刊
CARDIOVASCULAR DIABETOLOGY
卷 19, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12933-020-01158-6
关键词
Beck Depression Inventory; Cardiovascular risk; Depression; Framingham risk score; Obesity; Proprotein Converatse Subtilisin; Kexin type 9
资金
- Cariplo Foundation [2015-0552, 2018-0511]
- University of Milan Intramural Grant PSR 2018
- EU Programme 'Ideas', European Research Council [ERC-2011-StG 282,413]
- MIUR Progetto Eccellenza
Background Depression and cardiovascular disease (CVD) are among the most common causes of disability in high-income countries, depression being associated with a 30% increased risk of future CV events. Depression is twice as common in people with diabetes and is associated with a 60% rise in the incidence of type 2 diabetes, an independent CVD risk factor. Proprotein convertase subtilisin/kexin type 9 (PCSK9), a key regulator of low-density lipoprotein cholesterol, has been related to a large number of CV risk factors, including insulin resistance. Aim of this study was to investigate whether the presence of depression could affect PCSK9 levels in a population of obese subjects susceptible to depressive symptoms and how these changes may mediate a pre-diabetic risk. Results In 389 obese individuals, the Beck Depression Inventory (BDI-II) was significantly associated with PCSK9 levels. For every one-unit increment in BDI-II score, PCSK9 rose by 1.85 ng/mL. Depression was associated also with the HOMA-IR (homeostatic model assessment index of insulin resistance), 11% of this effect operating indirectly via PCSK9. Conclusions This study indicates a possible mechanism linking depression and insulin resistance, a well-known CV risk factor, providing evidence for a significant role of PCSK9.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据